
|Videos|December 14, 2021
Dr. Kutikov discusses recent NCCN guideline reversal on active surveillance
Author(s)Urology Times staff
Advertisement
In this video, Alexander Kutikov, MD, FACS, discusses the recent National Comprehensive Cancer Network guideline reversal regarding active surveillance in men with low-risk prostate cancer. Kutikov is the chief of the division of urology and urologic oncology, professor in the department of surgical oncology, and the Roberta R. Scheller Chair in urologic oncology at the Fox Chase Cancer Center at Temple University in Philadelphia, Pennsylvania.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA approves cefepime and zidebactam for complicated UTI
4
FDA updates in urology: May 2026
5











